Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of ...

In a randomized trial, both 100-mg and 300-mg monthly maintenance doses of extended-release buprenorphine improved opioid abstinence in patients with high-risk opioid use, with no new safety signals.

Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more likely to stay in treatment. Those on 17 to 24 milligrams averaged 190 ...

Please provide your email address to receive an email when new articles are posted on . As opioid dosage given during ventilation rose, so did the risk for opioid use after discharge. The risk for ...

The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed opioid medications is associated with a pattern of escalating opioid intake, ...

Feb 8 (Reuters) - A high-dose version of the opioid reversal spray naloxone, made by Hikma Pharmaceuticals (HIK.L), opens new tab, did not result in an increased survival rate compared with lower-dose ...

Most agree that there is no proven benefit from the chronic use of opioids (Vicodin, Oxycontin, Fentanyl) for non-cancer pain. From the Centers for Disease Control and Prevention, studies show nothing ...